Interplay between Mast Cells and Regulatory T Cells in Immune-Mediated Cholangiopathies
Immune-mediated cholangiopathies are characterised by the destruction of small and large bile ducts causing bile acid stasis, which leads to subsequent inflammation, fibrosis, and eventual cirrhosis of the liver tissue. A breakdown of peripheral hepatic immune tolerance is a key feature of these dis...
Main Authors: | Natalia M. Krajewska, Rémi Fiancette, Ye H. Oo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/11/5872 |
Similar Items
-
New Therapeutic Targets in Autoimmune Cholangiopathies
by: Alessio Gerussi, et al.
Published: (2020-04-01) -
The role of miRNAs in the development of cholangiopathies. Part 1
by: A.E. Abaturov, et al.
Published: (2023-06-01) -
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
by: Ji-Won Park, et al.
Published: (2022-05-01) -
Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial
by: Ruth Bolier, et al.
Published: (2017-05-01) -
Management of Autoimmune Liver Diseases after Liver Transplantation
by: Romelia Barba Bernal, et al.
Published: (2021-05-01)